SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Arcolab
Strides Arcolab
BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 30, 16:30
932.10
31.1 (3.45%)
VOLUME 105,463
LIVE
NSE
Jan 30, 16:30
932.45
32.8 (3.65%)
VOLUME 621,920
News on Strides Arcolab
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Strides Arcolab's Q3 results on Feb 02, 2015

3.08 pm | 23 Jan 2015 |  Source: Moneycontrol.com

Strides Arcolab Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 02, 2015, inter alia, to conside...

Buy Tata Motors DVR, HPCL, Strides Acrolab: Gaurav Bissa 

2.48 pm | 20 Jan 2015 |  Source: CNBC-TV18

Gaurav Bissa of LKP Securities recommends buying Tata Motors (DVR), HPCL and Strides Acrolab....

Strides in licensing pact with Gilead Science for HIV drug

12.00 pm | 20 Jan 2015 |  Source: Moneycontrol.com

Under the pact, Gilead has extended non-exclusive rights to Strides to manufacture and distribute Under the pact, Gilead has extended non-exclusive ri...

Patent denied on Gilead's Hepatitis C drug Sovaldi

8.49 pm | 15 Jan 2015 |  Source: CNBC-TV18

The order is a big set back for Gilead. The patent denial comes close to a decade after Gilead first filed its patent application and was close to a l...

Singapore's Economic Development Board grants International Headquarter status to Strides Pharma Global

10.34 am | 13 Jan 2015 |  Source: Moneycontrol.com

Strides Arcolab’s wholly owned subsidiary Strides Pharma Global Pte Singapore has been awarded International Headquarters Status by the Singapore Econ...

Buy Strides Arcolab, Siemens: Gaurav Bissa 

3.24 pm | 12 Jan 2015 |  Source: CNBC-TV18

Gaurav Bissa of LKP Securities advises buying Strides Arcolab, Power Finance Corporation and Siemens....

Prefer Wockhardt, Strides Arcolab: Gaurav Bissa 

4.22 pm | 05 Jan 2015 |  Source: CNBC-TV18

Gaurav Bissa, Derivatives Analyst at LKP Securities prefers Wockhardt and Strides Arcolab from the midcap pharma space....

Buy BHEL, Strides Arcolab: Manas Jaiswal 

2.42 pm | 31 Dec 2014 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com advises buying Strides Arcolab and BHEL....

Prefer Strides Arcolab, says Rahul Arora 

2.53 pm | 26 Dec 2014 |  Source: CNBC-TV18

Rahul Arora, CEO at Nirmal Bang Institutional Equities prefers Strides Arcolab....

See 9500 on Nifty by Diwali; upbeat on Strides: Nirmal Bang 

12.31 pm | 26 Dec 2014 |  Source: CNBC-TV18

Foreign institutional investors would be watching the Budget far more keenly than domestic investors and in case the Budget delivers on expected lines...

Buy Strides Arcolab; target of Rs 900: Religare Capital

2.34 pm | 12 Sep 2014 |  Source: Moneycontrol.com

Religare Capital is bullish on Strides Arcolab and has recommended buy rating on the stock with a target of Rs 900 in its September 11, 2014 research ...

1 2
Quick Links for Strides Arcolab
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.